Combining rejuvenation interventions in rodents: a milestone in biomedical gerontology whose time has come
Open Access
- 18 March 2024
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 28 (6) , 501-511
Abstract
Longevity research has matured to the point where significantly postponing age-related decline in physical and mental function is now achievable in the laboratory and foreseeable in the clinic. The most promising strategies involve rejuvenation, i.e. reducing biological age, not merely slowing its progression. We discuss therapeutic strategies for rejuvenation and results achieved thus far, with a focus on in vivo studies. We discuss the implications of interventions which act on mean or maximum lifespan and those showing effects in accelerated disease models. While the focus is on work conducted in mice, we also highlight notable insights in the field from studies in other model organisms. Rejuvenation was originally proposed as easier than slowing aging because it targets initially inert changes to tissue structure and composition, rather than trying to disentangle processes that both create aging damage and maintain life. While recent studies support this hypothesis, a true test requires a panel of rejuvenation interventions targeting multiple damage categories simultaneously. Considerations of cost, profitability and academic significance have dampened enthusiasm for such work, but it is vital. Now is the time for the field to take this key step toward the medical control of aging.Keywords
Funding Information
- Longevity Escape Velocity (LEV) Foundation
This publication has 94 references indexed in Scilit:
- The million-molecule challenge: a moonshot project to rapidly advance longevity intervention discoveryGeroScience, 2023
- Rapid emergence of transcriptional heterogeneity upon molecular stress predisposes cells to two distinct states of senescenceGeroScience, 2022
- Associations between biomarkers of cellular senescence and physical function in humans: observations from the lifestyle interventions for elders (LIFE) studyGeroScience, 2022
- Treatment with the BCL-2/BCL-xL inhibitor senolytic drug ABT263/Navitoclax improves functional hyperemia in aged miceGeroScience, 2021
- Repurposing drugs to fight aging: The difficult path from bench to bedsideMedicinal Research Reviews, 2020
- WormBot, an open-source robotics platform for survival and behavior analysis in C. elegansGeroScience, 2019
- Repurposing FDA-approved drugs for anti-aging therapiesBiogerontology, 2016
- Longevity, aging and rapamycinCellular and Molecular Life Sciences, 2014
- Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancerEMBO Molecular Medicine, 2012
- High throughput screening in drug discoveryClinical and Translational Oncology, 2006